Literature DB >> 15117914

Geneticism of essential hypertension.

Friedrich C Luft1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117914     DOI: 10.1161/01.HYP.0000128242.41442.71

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  7 in total

1.  Pharmacogenetic study of statin therapy in cholesterol reduction.

Authors:  Theodore A Kotchen
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

Review 2.  Update on G-protein polymorphisms in hypertension.

Authors:  Haidong Zhu; Xiaoling Wang; Yanhui Lu; Joseph Poola; Zamena Momin; Gregory A Harshfield; Harold Snieder; Yanbin Dong
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

Review 3.  Opportunities and limitations of genetic analysis of hypertensive rat strains.

Authors:  Juan M Saavedra
Journal:  J Hypertens       Date:  2009-06       Impact factor: 4.844

4.  Association of KATP Gene Polymorphisms with Dyslipidemia and Ischemic Stroke Risks Among Hypertensive Patients in South China.

Authors:  Cheng Liu; Tianwang Guan; Yanxian Lai; Yan Shen
Journal:  J Mol Neurosci       Date:  2021-01-05       Impact factor: 3.444

Review 5.  Beyond genome-wide association studies: new strategies for identifying genetic determinants of hypertension.

Authors:  Xiaoling Wang; Bram P Prins; Siim Sõber; Maris Laan; Harold Snieder
Journal:  Curr Hypertens Rep       Date:  2011-12       Impact factor: 5.369

6.  Essential hypertension in adolescents and children: Recent advances in causative mechanisms.

Authors:  Manu Raj
Journal:  Indian J Endocrinol Metab       Date:  2011-10

7.  Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China.

Authors:  Yizhi Pan; Tianyi Wang; Yanfang Li; Tianwang Guan; Yanxian Lai; Yan Shen; Abudurexiti Zeyaweiding; Tutiguli Maimaiti; Fang Li; Haiyan Zhao; Cheng Liu
Journal:  Lipids Health Dis       Date:  2018-10-20       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.